Transforming kidney science
Simple, elegant solution
Roivios® is a medical device company pioneering a novel renal assist device designed to sustain or enhance kidney function for patients who are at elevated risk.
Initially focused on meeting an unmet need of worsening renal function during on-pump cardiac surgery, our pioneering renal assist device has the potential to address a range of poor outcomes.
Our first product, the JuxtaFlow® Renal Assist Device, is the world’s first negative pressure renal assist device, and features a catheter with unique energy delivery.
Caution – Investigational Device, Limited by United States Law to Investigational Use Only. Not available for sale in the United States.
Company Profile
Untapped market opportunity
Strong customer demand
Compelling financial return
Pioneering intellectual property
Experienced veteran team
Leadership Team
John Erbey, PhD
Chief Executive Officer
John is the founder and CEO of Roivios. He has spent the past 25 years bringing innovative therapeutics and medical devices to the market.
Prior to founding Roivios, John held roles of increasing responsibility across the pharmaceutical and medical device industries.
He holds a PhD in epidemiology from the University of Pittsburgh’s Graduate School of Public Health. His dissertation on the cardiovascular risk associated with insulin resistance in adults with type 1 diabetes earned him induction into Delta Omega, the National Honor Society for Public Health. He has published 17 peer reviewed articles and delivered dozens of conference presentations and invited lectures.
Bryan Tucker, PhD
Sr. Vice President,
Applied Science
Bryan is the Senior Vice President of Applied Science at 3ive Labs. He brings over 30 years of experience in the medical device and pharmaceutical industries.
Prior to joining 3ive, Bryan held roles of increasing responsibility across R&D, clinical, and regulatory affairs across large cap device and startup companies. Bryan created and was head of clinical research at Aurora Health Care, a major health care organization in Wisconsin. He has a 15-0 record with the FDA on successful submissions. In addition, he has been a CEO, COO and held two Board seats. Prior to industry, he was on the faculty of the University of California at San Diego, in the Division of Nephrology and Hypertension. His research was focused on renal pathophysiology and volume homeostasis.
He holds a PhD in Biomedical Sciences, an MS in Bioengineering and a BS in Biology. He has published over 55 peer reviewed papers, three book chapters, more than 75 abstracts and served as a principal investigator on research grants from NIH, NASA, and pharmaceutical companies.
Malcolm St. John
Chief Financial Officer
Malcolm is the Chief Financial Officer at Roivios. He brings over 20 years of experience in the financial services industry.
Prior to joining Roivios, Malcolm served as CFO of System73 and held various senior leadership roles with highly regulated fund administrators, including Apex Fund Services and Mainstream Fund Services. He started his career at HSBC Bank where his role evolved within various departments in the bank.
Jacob Upperco
Sr. Director, Research & Development
Jacob is the Senior Director of R&D at 3ive Labs. He brings 10 years of experience with medical device design and development.
Prior to joining 3ive, he conceptualized, built and tested medical devices for use by physicians and scientists across various clinical research applications, including biomechanical diagnostics, medical image processing and interventional cardiology.
He holds an MBID from the Georgia Institute of Technology and a BS in biomedical engineering from Tulane University. He has co-authored dozens of issued patents and several peer reviewed articles.
ALENCIA WASHINGTON, PhD
Vice President, Clinical Affairs
Alencia Washington serves as the vice president of clinical affairs at Roivios, where she brings her extensive background in biomedical engineering and cardiovascular disease research to the forefront.
Starting her career as a biomedical engineer, Alencia quickly ascended the ranks of the medical field. She held senior research positions at both Kimberly-Clark Corporation and Avanos
Medical, where she helped drive advancements in their respective fields. Her work caught the attention of Wellstar Health System, where she served as assistant vice president of research administration, overseeing research activities across its vast network of hospitals and ambulatory centers.
Alencia completed her doctoral studies at the University of Alabama at Birmingham, specializing in the immune response in cardiovascular diseases. She then went on to complete a clinical pharmacology and experimental therapeutics fellowship under Dr. Nancy J. Brown at Vanderbilt University.
Learn about our research
Find info about our clinical studies
See how JuxtaFlow works
Discover our solution
Learn about Renal Insufficiency
Understand the condition
